The Global Stem Cell Banking Market is Anticipated to Witness Considerable Growth Due to Rising Awareness About Stem Cell Therapies

 

stem cell banking market

Stem cell banking is the process of collecting, processing and storing of stem cells, commonly from umbilical cord blood and tissue for future use in transplantation and research activities. Stem cells present in umbilical cord blood offer advantages like lower risk of transmitting infections, higher proliferation potential, and ability to treat a wider range of blood and immune disorders. Cord blood is collected from the umbilical cord and placenta after birth and the stem cells within are isolated and cryogenically frozen and stored in specialized stem cell banks for future medical need.

The global stem cell banking market size was valued at US$ 616.11 Mn in 2024 and is expected to exhibit a CAGR of 5.4% over the forecast period 2024 -2030.

 

Key players operating in the stem cell banking market are CM Fine Chemicals GmbH, Hawks Chemical Company, Hebei Yingong New Material Technology Co., Ltd., Heranba Industries Ltd., Jiangsu Dacheng Pharmaceutical and Chemical Co., Ltd., Luyunjia Chemistry Xiamen Limited, Merck KGaA, Mody Chemi-Pharma Limited, RX MARINE INTERNATIONAL, and Yancheng Longsheng Chemical Co., Ltd. The growing prevalence of blood disorders and genetic diseases as well as rising awareness about stem cell therapies is fuelling the demand for cord blood banking services globally. Furthermore, advancements in stem cell therapies are projected to enhance treatment outcomes which will also accelerate the market growth.

 

Key Takeaways:

 

Key players operating in the Global Stem Cell Banking Market Share are focusing on acquisition and regional expansion strategies to consolidate their market share. CM Fine Chemicals GmbH acquired a leading stem cell bank in 2022 to expand its storage capacities.

 

The growing demand for treatment of blood disorders such as leukemia, thalassemia and metabolic diseases is driving individuals to opt for stem cell banking services. Nearly 1 million stem cell transplants have been performed globally according to World Marrow Donor Association.

 

North America dominates the global stem cell banking market owing to increasing usage of these cells in disease treatment and presence of supportive government regulations regarding cord blood banking. However, Asia Pacific market is expected to witness highest CAGR during the forecast period with expanding healthcare infrastructure and increasing healthcare expenditure in countries like China and India.

 

Market drivers:

 

Rising prevalence of chronic diseases is a key factor propelling the demand for umbilical cord blood storage globally. Diseases such as cancer, blood disorders may require stem cell transplant procedures in future. As per WHO, around 10 million new cancer cases emerge yearly worldwide.

 

Growing awareness about the therapeutic benefits of umbilical cord stem cells and established medical reimbursements for private cord blood banking in developed nations are positively impacting the market growth. Additionally, increasing R&D investments by pharmaceutical companies in developing stem cell therapies will continue driving the stem cell banking industry during the forecast period.

 

The current geopolitical uncertainties have impacted the growth of the stem cell banking market. The conflict between Russia and Ukraine has disrupted supply chains and created instability in Europe. As medical tourism and stem cell collection from umbilical cord blood has reduced between these nations, market players have faced challenges. Companies operating in this region are exploring strategic partnerships and investing in automation to minimize disruptions. While outsourcing of non-core functions can help offset short term impacts, long term strategies will need to focus on developing local stem cell collection capabilities and infrastructure in multiple regions to reduce overdependence on single regions and countries. Boosting domestic capabilities will help insulate the market from external political and economic shocks in the future.

 

North America holds the largest share of the stem cell banking market in terms of value currently. This is attributed to favorable regulatory environment and increasing initiatives by both public and private organizations to spread awareness about stem cell therapy and banking. However, Asia Pacific region is projected to grow at the fastest rate during the forecast period. Increasing healthcare expenditure, rising awareness about stem cell therapies, and supportive government initiatives in countries like China and India are some major factors driving regional market growth. Coupled with growing medical tourism industry, Asia Pacific offers immense opportunities for stem cell banking market players in the coming years.

 

The United States currently accounts for over 35% of the global stem cell banking market value and is the largest regional market. High clinical research activity, widespread healthcare infrastructure, availability of private and public banking facilities and supportive regulatory framework have boosted market growth. However, China is expected to surpass the US and become the leading stem cell banking market in the world by 2028 given its increasing healthcare investments, large patient pool for diseases treatable by stem cells, and government thrust on indigenous research. Growing penetration of commercial and public banking facilities along with strengthening of regulatory guidelines will fuel further expansion of the stem cell banking industry in China and other Asian nations going forward.


Get More Insights Here

https://www.newsanalyticspro.com/stem-cell-banking-market-size-share-growth-outlook-2023/

Comments

Post a Comment

Popular posts from this blog

"Global Heparin Market: Current Trends and Future Prospects"

Image
  Heparin, a crucial anticoagulant, has been a mainstay in the pharmaceutical industry for many years. It plays a pivotal role in preventing and treating conditions such as deep vein thrombosis, pulmonary embolism, and various cardiovascular diseases. As we delve into the current state of the heparin market, we will explore the trends, challenges, and opportunities that shape this vital segment of the pharmaceutical industry. Market Overview: The global heparin market has experienced steady growth over the years, driven by an aging population, increasing cases of cardiovascular diseases, and a rising awareness of the importance of anticoagulants in healthcare. Heparin is available in various forms, including unfractionated heparin (UFH) and low molecular weight heparin (LMWH), each with its own set of applications and market dynamics. Trends: 1.      Rising Demand for LMWH : Low molecular weight heparin is gaining popularity due to its ease of administr...
Read more

"Advancements in Cystic Fibrosis Treatment: A Comprehensive Market Analysis"

Image
  The cystic fibrosis market has seen significant advancements and changes in recent years. Cystic fibrosis is a genetic disorder that affects the lungs and digestive system, leading to thick and sticky mucus production that can cause serious respiratory and digestive complications. The introduction of new therapies and treatments, such as CFTR modulators, has revolutionized the management of cystic fibrosis, offering hope and improved quality of life for patients. These drugs target the underlying genetic mutations responsible for the condition, helping to alleviate symptoms and slow disease progression. However, challenges remain in the cystic fibrosis market . Access to these ground-breaking therapies can be limited due to high costs, and ongoing research is needed to develop treatments for all genetic mutations associated with the disease. Additionally, the market continues to evolve as new therapies and innovations emerge. Collaborative efforts between pharmaceutical compani...
Read more

Botanical Packaging is Estimated to Witness High Growth Owing to Growing Environmental Concerns

Image
  Botanical Packaging Market Botanical packaging involves using various plant-based materials like corn starch, wheat starch, soy protein, bamboo, bagasse as raw materials for manufacturing boxes, cartons, bags and wrapping films for packaging applications. These biodegradable materials offer attractive sustainability advantages over traditional petroleum-based plastics. Botanical packaging finds widespread application in food, beverage, pharmaceutical, personal care and homecare industries for primary, secondary and tertiary packaging needs. The global botanical packaging Market is estimated to be valued at US$ 138.24 Bn in 2023 and is expected to exhibit a CAGR of 34% over the forecast period 2024 to 2031.   Market Dynamics: Growing environmental concerns about the menace of plastic pollution have been fuelling adoption of sustainable packaging alternatives globally. One of the key drivers for botanical packaging market is the stringent government policies and regulati...
Read more